Long-term Follow-up of Nivolumab and Ipilimumab- (as Monotherapy and as Combination Therapy)-treated Pediatric Patients Enrolled in the Dutch Melanoma Treatment Registry (DMTR) First published 13/05/2019 Last updated 30/01/2026 EU PAS number:EUPAS29722 Study Ongoing